PLN 230 million for the increase of competitiveness and innovativeness of Polish pharmacy


The National Center for Research and Development announced the InnoNeuroPharm call, which aims to increase the competitiveness and innovation of the Polish pharmaceutical sector, including neuromedicine, in the perspective of 2026. PLN 230 million has been allocated to the program.
The InnoNeuroPharm sector program was created on the initiative of the Polish Association of Employers of the Pharmaceutical Industry and the Polish Innovation Platform of Neuromedicine. The research areas of the InnoNeuroPharm sector program include innovative medicinal products, innovative technologies for the production of medicinal products, innovative diagnostic methods and new biomarkers with practical diagnostic-predictive applications in the field of neuromedicine, innovative methods of rehabilitation of neuromedicine patients, development of tools supporting research on medicinal products.

Innovations Medicine and biotechnology Research and development